Hepatology Trials



Gastroenterology Hepatology



Liver, Biliary, & Pancreatic Disorders


Hepatology




Liver & Kidney Transplant Trial

Hepatology Trials

Contact Name	Monique Williams, RN, BSN, Clinical Coordinator
Contact Phone	(312) 563- 3919
Contact E-mail	Monique_Williams@rush.edu

Please click on the links below to learn about clinical research trials in hepatology (liver disease). If no studies are listed, contact Monique Williams, RN, BSN, Clinical Coordinator, at (312) 563- 3919 (or via e-mail at Monique_Williams@rush.edu) to inquire about studies under way.

If you would like to make an appointment with a physician at Rush, call (888) 352-RUSH, our toll-free referral line.

Included in this section:

Assessment of Long Term Outcomes on Entecavir: A study on the observational assessment of long term outcomes on Entecavir

Decompensated Hepatitis B Trial: This is double blinded study to evaluate and compare the safety and tolerability of tenofovir disoproxil fumarate, emtricitabine plus tenofovir disoproxzil fumarage, and entecavir in the treatment of chronic hepatitis B subjects decompensated liver disease.

Liver & Kidney Transplant Trial: Effectiveness Study of Changing Immunosuppressive Drugs in Kidney and Liver Patients Who Have Developed Abnormal Glucose Levels

Open label Partial Responders to Peginterferon: A study is to compare the efficacy and safety of Infergen

Pegasys and Hepatitis C: A study measuring the efficacy and safety of Pegasys.



Clinical Trials Home Hepatology Trials Decompensated Hepatitis B Trial Liver & Kidney Transplant Trial Observational Assessment of Long Term Outcomes on Entecavir Open Label Partial Responders to Peginterferon Pegasys and Hepatitis C